Clinical trial Recruiting at 2 sites Interventional Ages 18 to 65

Virtual reality gait exercises for lower limb lymphedema (LELO)

Official title: The Effect of Virtual Reality-Assisted Exercises on Gait Parameters, Function, Quality of Life, and Edema Level in Patients With Lower Extremity Lymphedema

Run by Gaziler Physical Medicine and Rehabilitation Education and Research Hospital · NCT07472543 · Data updated 2026-11-12

This trial will test whether adding VR-assisted gait training to standard Complex Decongestive Therapy helps adults with unilateral stage 2–3 lower limb lymphedema walk better, reduce swelling, and improve quality of life.

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment40 (estimated)
SponsorGaziler Physical Medicine and Rehabilitation Education and Research Hospital
Academic / other
Locations2 sites (Ankara and 1 other locations)
StatusRecruiting
StartedSeptember 1, 2025
Main results expectedSeptember 1, 2026
Study endsOctober 1, 2026
Registry record updatedMarch 16, 2026
Trial IDNCT07472543 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults age 18–65 with unilateral stage 2 or 3 lower extremity lymphedema following gynecologic or oncologic surgery who can attend treatment five days per week for four weeks.

Probably not a fit

Patients with bilateral lymphedema, lipolymphedema, active infections, uncontrolled systemic disease, neuromuscular or orthopedic conditions that affect walking, active metastasis, pregnancy, or inability to adhere to the treatment schedule are unlikely to benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a randomized controlled trial comparing Complex Decongestive Therapy (CDT) plus VR-assisted gait training (using systems such as RehaWalk) versus CDT alone in patients with unilateral lower extremity lymphedema. Participants undergo daily sessions five days a week for four weeks, with outcomes measured before and after treatment. Primary and secondary outcomes include spatiotemporal gait parameters, three-zone foot loading analysis, limb circumferences, ultrasound measurements of skin and subcutaneous tissue, and patient-reported function and quality of life. The trial is conducted at Gaziler Physical Medicine and Rehabilitation in Ankara and enrolls adults with stage 2–3 post-surgical lymphedema.

Why it matters

Potential benefit: If successful, adding VR gait training could improve walking function, reduce edema-related changes, and increase treatment engagement beyond standard CDT alone.

How similar studies have gone: VR-based gait and motor training have shown benefits for gait and engagement in other rehabilitation populations, but application specifically to lower limb lymphedema is relatively novel and limited in prior evidence.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age between 18 and 65 years
* Diagnosis of unilateral lower extremity lymphedema following gynecological and/or oncological surgery
* Stage 2 or 3 lymphedema

Exclusion Criteria:

* Decompensated heart, lung, or kidney failure
* Uncontrolled hypertension
* Presence of systemic infection
* Local infections in the lower extremity such as erysipelas or cellulitis
* Venous insufficiency (e.g., deep vein thrombosis)
* Any neuromuscular or orthopedic disease affecting lower extremity walking
* Presence of balance disorders
* Bilateral lymphedema
* Presence of lipolymphedema
* Fracture in the lower extremity
* Active metastasis
* Speech or language problems
* Pregnancy
* Inability to continue treatment (5 days a week for a total of 4 weeks)

Where it's running

  • Ankara Gaziler physical therapy and rehabilitationhospital
    Ankara, Turkey (Türkiye)
    Recruiting
  • Gaziler physical therapy and rehabilitation
    Ankara, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.